APA (7th ed.) Citation

Mock, A., Geisenberger, C., Orlik, C., Warta, R., Schwager, C., Jungk, C., . . . Herold-Mende, C. (2016). LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients. International journal of cancer, 139(2), . https://doi.org/10.1002/ijc.30069

Chicago Style (17th ed.) Citation

Mock, Andreas, et al. "LOC283731 Promoter Hypermethylation Prognosticates Survival After Radiochemotherapy in IDH1 Wild-type Glioblastoma Patients." International Journal of Cancer 139, no. 2 (2016). https://doi.org/10.1002/ijc.30069.

MLA (9th ed.) Citation

Mock, Andreas, et al. "LOC283731 Promoter Hypermethylation Prognosticates Survival After Radiochemotherapy in IDH1 Wild-type Glioblastoma Patients." International Journal of Cancer, vol. 139, no. 2, 2016, https://doi.org/10.1002/ijc.30069.